SGMO: Rasio kapitalisasi pasar marang pendapatan Sangamo Therapeutics Inc.

Simbol lan logo merek Sangamo (SGMO)

Sangamo Therapeutics brings together top geneticists equipped with the resources to save lives. However, the business is currently undergoing a sharp model shift toward IT platforms for patent licensing. The price-to-sales ratio helps align these transformations with market value, where the current level is 1.90. This approach confirms the company's status as a pioneer in applying ZFP nucleases to combat severe pathologies.

SGMO Rasio rega marang pendapatan sangamo.com (04.07.2022 - 09.05.2026)

Rincian metrik lan analitis perusahaan Sangamo (SGMO)

Analisis umum perusahaan:SGMO - Sangamo
Produk mawa merek Sangamo Therapeutics Inc.

Sangamo Therapeutics (SGMO) monetizes its patents through upfront payments from pharma giants, ensuring a steady revenue stream that determines the business's fundamental value. The price-to-sales ratio, illustrated on the Sangamo Therapeutics (SGMO) P/S chart, measures the premium for future growth, allowing investors to timely identify asset overvaluation or find an entry point during abnormal price fluctuations.

Karo sapa Sangamo Therapeutics saingan

TEM (Tempus AI, Inc.) - Rasio kapitalisasi pasar marang pendapatan|Qiagen Group - Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan IONS|RGEN - Rasio rega marang pendapatan|Koefisien rega marang pendapatan Avidity Biosciences RNA|CRSP: Multiplikator P/S|Rasio kapitalisasi marang pendapatan WGS|RARE (Ultragenyx Pharma) - Multiplikator P/S|Multiplikator P/S Beam Therapeutics Inc.|Rasio rega marang pendapatan Sarepta Therapeutics Inc (SRPT)|Twist Bioscience - Rasio kapitalisasi marang pendapatan|10x Genomics Inc - Kapitalisasi marang pendapatan|NTLA (Intellia Therapeutics, Inc.) - Rasio rega marang dodolan|Stoke Corp - Multiplikator P/S|BLFS (BioLife) - Rasio kapitalisasi marang pendapatan|wavelifesciences.com (WVE) - Rasio rega marang pendapatan|MAZE - Koefisien rega marang pendapatan|SION (Sionna Therapeutics, Inc.) - Multiplikator P/S|Kapitalisasi marang pendapatan Prime Medicine Corp (PRME)|Multiplikator P/S TSHA|Multiplikator P/S uniQure N.V. (QURE)|Rasio rega marang pendapatan MeiraGTx Holdings plc MGTX|RGNX: Rasio kapitalisasi marang pendapatan|Solid Biosciences Inc - Multiplikator P/S|OCGN - Multiplikator P/S|PACB: Multiplikator P/S|BNTC - Koefisien rega marang pendapatan|Rasio rega marang pendapatan Design Therapeutics, Inc.|RCKT: Rasio kapitalisasi pasar marang pendapatan|Kapitalisasi marang pendapatan FDMT (4D Molecular Therapeutics, Inc.)|Lexeo Therapeutics, Inc. - Rasio kapitalisasi marang pendapatan|Rasio rega marang pendapatan Korro Bio, Inc. KRRO|EDIT: Rasio kapitalisasi marang pendapatan|SLN - Rasio rega marang pendapatan|Multiplikator rega marang pendapatan ProQR Therapeutics (PRQR)|CDXS (Codexis Bio) - Kapitalisasi marang pendapatan|Rasio kapitalisasi marang pendapatan NAUT|Rasio rega marang pendapatan metagenomi.co|Multiplikator P/S Precision BioSciences Inc.|Multiplikator P/S GBIO|Boundless Bio, Inc. - Rasio kapitalisasi marang pendapatan|Multiplikator P/S XCUR (Exicure, Inc.)|Koefisien rega marang pendapatan Imunon, Inc. (IMNN)|PHIO - Rasio rega marang pendapatan|Rasio kapitalisasi pasar marang pendapatan MBIO (mustangbio.com)|RNAZ: Multiplikator P/S|Rasio kapitalisasi marang pendapatan BNGO|APDN (Applied DNA Corp) - Multiplikator P/S|BLUE: Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan ImmunoPrecise (IPA)|OMGA - Rega marang dodolan|Rasio rega marang pendapatan Singular Genomics OMIC|Rasio kapitalisasi pasar marang pendapatan RGLS|Syros Pharmaceuticals, Inc. - Multiplikator P/S|Koefisien rega marang pendapatan Telesis Bio Inc. TBIO|TRACON Pharmaceuticals, Inc. (TCON) - Rasio rega marang pendapatan|Unity Biotechnology, Inc - Rasio kapitalisasi pasar marang pendapatan